medline.ch Onkologie Blut

	Systemic Retinoids in Cutaneous T-Cell Lymphoma: A Scoping Review of Clinical Use and Evidence Gaps. Dermatol Ther (Heidelb) Bui T, Niknejad K, Urbanski N, Fidan DG, Wolner Z, Rozati S. PMID: 42828677 [PubMed - as supplied by publisher]
	Machine learning-based early prediction of severe pneumonia risk in hospitalized leukemia patients: a dual-center retrospective cohort study. Front Cell Dev Biol Huang J, Wu Q, Zhang Y, Wang K, Wang Y, Tang C, Li C, Lin N. PMID: 42827898 [PubMed]
	All-Oral PI3KÎ´ and HDAC Inhibition with Parsaclisib Plus Chidamide and Step-Down Maintenance in Relapsed or Refractory Peripheral T-Cell Lymphoma: A Phase Ib Trial. MedComm (2020) Luo X, Yan Z, Fang W, Duan H, Zhang Q, Wang H, Yao S, Zhang J, Jin Y, Li W, Teng X, Zhang L, Liang L, Lin Q, Wang P, Si H, Miao J, Zhou W, Yao Z, He YW, Xia Q, Liu Y. PMID: 42827632 [PubMed]
	The ferroptosis-cuproptosis crosstalk in hematological malignancies: multi-omics insights into gene-regulated cell death and emerging therapeutic opportunities. Apoptosis Antal S, Anshu T, Goswami PK, Kumar D, Choudhary N, Kadam AD. PMID: 42829391 [PubMed - indexed for MEDLINE]
	First-line ibrutinib-venetoclax in chronic lymphocytic leukemia: GLOW 67-month results and grade 3/4 adverse event-free progression-free survival. Leukemia U Niemann C, Munir T, Owen C, Follows G, Hernández-Rivas JÁ, Benjamini O, Janssens A, Levin MD, Robak T, Simkovic M, Voloshin S, Vorobyev V, Ysebaert L, Schuier N, Baeten K, Tran N, Levitan B, Kavanagh C, Kater AP. PMID: 42827117 [PubMed - as supplied by publisher]
	Inhibition of ROR1 signaling with zilovertamab plus ibrutinib in chronic lymphocytic leukemia: safety, mechanistic insights, and an exploratory signal in del(17p) disease. Leukemia Choi MY, Ghia EM, Siddiqi T, Barrientos JC, Tuscano J, Koff JL, Yazji S, Leslie LA, Isufi I, Lamanna N, Goldenberg A, Chung G, Subbiah S, Robinson JM, O'Neill S, Jamieson CHM, Breitmeyer JB, Wierda WG, Kipps TJ. PMID: 42827116 [PubMed - as supplied by publisher]
	Phase 1/2 study of favezelimab plus pembrolizumab in anti-PD-1-naive relapsed or refractory classical Hodgkin lymphoma. Blood Adv Johnson NA, Lavie D, Borchmann P, Gregory GP, Herrera AF, Minuk L, Vucinic V, Armand P, Avigdor A, Gasiorowski R, Herishanu Y, Keane C, Kuruvilla J, Marceu West R, Pillai PM, Marinello P, Timmerman JM. PMID: 42826707 [PubMed - as supplied by publisher]
	Medium-Term Cognitive Outcome in Patients With CNS Lymphomas Treated With Chimeric Antigen Receptor T-Cell Therapy. Neurology Mersali S, Chapelle R, Ribeiro M, Weiss N, Psimaras D, Le Guennec L, Birzu C, Hoang-Xuan K, Boussen I, Baron M, Morel V, Uzunov M, Friser V, Choquet S, Houillier C. PMID: 42826379 [PubMed - indexed for MEDLINE]
	Primary pulmonary mucosa-associated lymphoid tissue lymphoma presenting as a right hilar mass: A case report. Medicine (Baltimore) Fu L, Zeng T, Hong C, Zhang Y, Huang H. PMID: 42826325 [PubMed - indexed for MEDLINE]
	Angioimmunoblastic T-cell lymphoma with secondary hemophagocytic lymphohistiocytosis initially misdiagnosed as classical Hodgkin lymphoma: A case report. Medicine (Baltimore) Li R, Chen Y, Liu X, Gao Y, Zhu N, Deng C, Li Y. PMID: 42826277 [PubMed - indexed for MEDLINE]
	Concurrent presentation of distinct extranodal and splenic marginal zone lymphomas. J Hematop Grevet JD, Zhang Y, Sadigh S, Kim AI. PMID: 42825886 [PubMed - indexed for MEDLINE]
	Pembrolizumab-GVD in relapsed or refractory Hodgkin lymphoma: 5-year update of a multicenter phase 2 trial. Blood Patel K, Shah GL, Schöder H, Ganesan N, Drill E, Hancock H, Davey T, Santarosa AM, Galasso N, Kumar A, Lahoud OB, Hamlin PA, Straus DJ, Owens CN, Caron PC, Intlekofer AM, Horwitz SM, Falchi L, Palomba ML, Noy A, Matasar MJ, Salles GA, Vardhana SA, Wills B, Yahalom J, Dogan A, Zelenetz AD, Wong P, Toyomura M, Michaud L, Sen F, Argyropoulos KV, Moskowitz CH, Moskowitz AJ. PMID: 42825495 [PubMed - as supplied by publisher]
	One cycle of nelarabine given after induction is well tolerated but does not improve outcome in adults with T-cell precursor acute lymphoblastic leukemia: Outcome data from the UKALL14 randomized-controlled trial. Hemasphere Rowntree CJ, Kirkwood AA, Farah N, Lawrie E, Marks DI, McMillan AK, Menne TF, Moorman AV, Patel B, Patrick P, Smith P, Alapi KZ, Wang L, Mansour MR, Fielding AK. PMID: 42824995 [PubMed]
	Plasmablastic Richter Transformation of Chronic Lymphocytic Leukemia With Aberrant Epithelial Marker Expression Presenting as a Pleural Effusion: A Diagnostic Challenge. Case Rep Pathol Rogers J, Akhter JZ, Rosa M, Niyazi S, Werner-Idiaquez D, Pinilla-Ibarz J, Grajales-Cruz A, Moscinski L, Ryder CB. PMID: 42824952 [PubMed]
	A Real-World Study of Tafasitamab for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma in the United States. EJHaem Saverno K, Nastoupil LJ, Feinberg B, Galvin J, Pathak P, Amoloja T, Gentile D, Asgarisabet P, Epperla N. PMID: 42824791 [PubMed]
	Enhanced Lymphoma Subtype Classification and Prognosis Using Machine Learning with (18)F-FDG PET/CT Radiomics: Beyond SUV(max). Nucl Med Mol Imaging Hasanabadi S, Aghamiri SMR, Abin AA, Vosoughi H, Emami F, Bakhshayesh Karam M, Nejabat M, Dorudinia A, Arabi H, Zaidi H. PMID: 42824644 [PubMed]
	Exercise intervention for children with acute leukemia: a best evidence summary. Front Pediatr Zhou W, Li L, Ma J, Zhou J. PMID: 42824391 [PubMed]
	Single-session therapeutic plasma exchange as salvage therapy for pegaspargase-induced severe acute pancreatitis accompanied by multiple organ dysfunction in a pediatric patient with B-cell precursor acute lymphoblastic leukemia: a case report. BMC Pediatr Dai J, Xiao Y, Han Y, Ye H, Xie S. PMID: 42823759 [PubMed - indexed for MEDLINE]
	Person-Based Progression in Acute Myeloid Leukemia Classification: A Multi-View Convolutional Neural Network Approach. J Imaging Inform Med Erda. PMID: 42823569 [PubMed - as supplied by publisher]
	Comparative Cost and Utilization Analysis of CAR-T Therapy and Autologous Stem Cell Transplantation for Diffuse Large B-Cell Lymphoma in Germany: Insights from Statutory Health Insurance Billing and Nationwide Inpatient Data. J Cancer Res Clin Oncol Froitzheim AC, Kurte MS, Gehrke K, Lempfert S, Hesse K, Kron F. PMID: 42823558 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 170607

Seite 1 von 8531

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung